Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Radiotherapy for Glioblastoma
NCT00006353Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2000
- Primary completion
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in glioblastoma multiforme (GBM), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00006353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006353.